Medical Design Technology -
21 May 2018 15:00
News Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections obsolete... Contributed Author: Rob Matheson, MIT News Topics: Implantables
Share this Article